Table 4

Disease stage at study enrollment and prior treatment of 30 patients treated with trastuzumab infusions and 5 control patients treated with immunoglobulin IgG

Patient numberDisease stage at study enrollmentNumber of prior chemotherapy regimensNumber of prior hormonal therapiesPatient enrollment on the study and time elapsed from previous systemic therapy
1I11After adjuvant hormonal therapy
2I11After adjuvant hormonal therapy
3I11After adjuvant hormonal therapy
4IIA11After adjuvant hormonal therapy
5IIA11After adjuvant hormonal therapy
6IIA11After adjuvant hormonal therapy
7IIA11After adjuvant hormonal therapy
8IIB11After adjuvant hormonal therapy
9IIB11After adjuvant hormonal therapy
10IIB11After adjuvant hormonal therapy
11IIIA11After adjuvant hormonal therapy
12IIIB11After hormonal therapy
13IIIB11After hormonal therapy
14IIIB11After hormonal therapy
15IV32After 2nd line hormonal therapy
16IV213 mo from 2nd line chemotherapy
17IV43After 4th line chemotherapy
18IV22After 2nd line hormonal therapy
19IV22After 2nd line hormonal therapy
20IV112 mo from 1st line hormonal therapy
21IV222 mo from 2nd line chemotherapy
22IV11After 1st line hormonal therapy
23IV32After 2nd line hormonal therapy
24IV22After 2nd line hormonal therapy
25IV32After 3rd line chemotherapy
26IV2After 2nd line chemotherapy
27IV23 mo from 2nd line chemotherapy
28IV31After 1st line hormonal therapy
29IV11After 1st line hormonal therapy
30IV25 mo from 2nd line chemotherapy
31IV21 mo from 2nd line chemotherapy
32IV1After 1st line chemotherapy
33IV126 mo from 2nd line hormonal therapy
34IV213 mo from 2nd line chemotherapy
35IV12After 2nd line hormonal therapy